Magnitude of bacteraemia is associated with increased mortality in non-typhoid salmonellosis: A one-year follow-up study

APMIS

Volumn 116, Issue 2, 2008, Pages 147-153

  Gradel, Kim O ^a,b   Dethlefsen, Claus ^a   Schønheyder, Henrik C ^a   Nielsen, Henrik ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Magnitude of bactaeremia; Mortality; Non typhoid salmonellosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; COMORBIDITY; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA BASE; DENMARK; DISEASE ASSOCIATION; DISEASE SEVERITY; FECES CULTURE; FEMALE; FOLLOW UP; GASTROENTERITIS; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SALMONELLOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SALMONELLA; SALMONELLA INFECTIONS;

EID: 40449089468     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00886.x     Document Type: Article

References (35)

1. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001 32: 263 9.
2. Landsman JB. Bacteriaemia and prognosis in lobar pneumonia: the results of quantitative blood culture in pneumococcus pneumonia. Glasgow Med J 1952 33: 33 45.
3. Hall WH, Gold D. Shock associated with bacteremia; review of thirty-five cases. AMA Arch Intern Med 1955 96: 403 12.
4. Weil MH, Spink WW. The schock syndrome associated with bacteremia due to gram-negative bacilli. AMA Arch Intern Med 1958 101: 184 93.
5. DuPont HL, Spink WW. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969 48: 307 32.
6. Kluge RM, DuPont HL. Factors affecting mortality of patients with bacteremia. Surg Gynecol Obstet 1973 137: 267 9.
7. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980 68: 332 43.
8. Whimbey E, Kiehn TE, Brannon P, Benezra D, Armstrong D. Clinical significance of colony counts in immunocompromised patients with Staphylococcus aureus bacteremia. J Infect Dis 1987 155: 1328 30.
9. Schønheyder HC, Gottschau A, Friland A, Rosdahl VT. Mortality rate and magnitude of Staphylococcus aureus bacteremia as assessed by a semiquantitative blood culture system. Scand J Infect Dis 1995 27: 19 21.
10. Gradel KO, Schønheyder HC, Pedersen L, Thomsen RW, Nørgaard M, Nielsen H. Incidence and prognosis of non-typhoid Salmonella bacteraemia in Denmark: a 10-year county-based follow-up study. Eur J Clin Microbiol Infect Dis 2006 25: 151 8.
11. Frank L. Epidemiology. When an entire country is a cohort. Science 2000 287: 2398 9.
12. Pedersen G, Schønheyder HC, Kristensen B, Sørensen HT. Community-acquired bacteraemia and antibiotic resistance. Trends during a 17-year period in a Danish county. Dan Med Bull 2000 47: 296 300.
13. Madsen KM, Schønheyder HC, Kristensen B, Sørensen HT. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981-1994. APMIS 1999 107: 346 52.
14. Gradel KO, Dethlefsen C, Schønheyder HC, Ejlertsen T, Sørensen HT, Thomsen RW, et al. Severity of infection and seasonal variation of non-typhoid Salmonella occurrence in humans. Epidemiol Infect 2007 135: 93 9.
15. Popoff MY, Le Minor L. Antigenic formulas of the Salmonella serovars. Paris, France: Institut Pasteur, 1997.
16. Schønheyder HC. [Two thousands seven hundred and thirty nine episodes of bacteremia in the county of Northern Jutland 1996-1998. Presentation of a regional clinical database]. Ugeskr Laeger 2000 162: 2886 91.
17. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999 46: 263 8.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40: 373 83.
19. Hosmer DW Jr., Lemeshow S. Assessment of model adequacy. In: Hosmer DW Jr. Lemeshow S. Applied Survival Analysis. New York: John Wiley & Sons, Inc., 1999.
20. Sullivan TD, LaScolea LJ Jr., Neter E. Relationship between the magnitude of bacteremia in children and the clinical disease. Pediatrics 1982 69: 699 702.
21. Sabui T, Tudehope DI, Tilse M. Clinical significance of quantitative blood cultures in newborn infants. J Paediatr Child Health 1999 35: 578 81.
22. Kiehn TE. Quantitative blood cultures. A review of 52 years. In: Brown AE, Armstrong D, editors. Infectious Complications of Neoplastic Diseases: Controversies in Management. New York: Yorke Medical Books, 1985.
23. Yagupsky P, Nolte FS. Quantitative aspects of septicemia. Clin Microbiol Rev 1990 3: 269 79.
24. Lamy B, Roy P, Carret G, Flandrois JP, Delignette-Muller ML. What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia. Clin Infect Dis 2002 35: 842 50.
25. Washington JA, Ilstrup DM. Blood cultures: issues and controversies. Rev Infect Dis 1986 8: 792 802.
26. Arpi M, Bentzon MW, Jensen J, Frederiksen W. Importance of blood volume cultured in the detection of bacteremia. Eur J Clin Microbiol Infect Dis 1989 8: 838 42.
27. Cockerill FRI, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS, et al. Optimal testing parameters for blood cultures. Clin Infect Dis 2004 38: 1724 30.
28. Arendrup M, Jensen IP, Justesen T. Diagnosing bacteremia at a Danish hospital using one early large blood volume for culture. Scand J Infect Dis 1996 28: 609 14.
29. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983 5: 54 70.
30. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity, a critical review of available methods. J Clin Epidemiol 2003 56: 221 9.
31. Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano F. Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 1994 19: 777 80.
32. Shimoni Z, Pitlik S, Leibovici L, Samra Z, Konigsberger H, Drucker M, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999 28: 822 7.
33. Brown M, Eykyn SJ. Non-typhoidal Salmonella bacteraemia without gastroenteritis: a marker of underlying immunosuppression. Review of cases at St. Thomas' Hospital 1970-1999. J Infect 2000 41: 256 9.
34. Hsu RB, Tsay YG, Chen RJ, Chu SH. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003 36: 829 34.
35. de Wit MA, Kortbeek LM, Koopmans MP, de Jager CJ, Wannet WJ, Bartelds AI, et al. A comparison of gastroenteritis in a general practice-based study and a community-based study. Epidemiol Infect 2001 127: 389 97.